Vertex Report Positive Results for Cystic Fibrosis Combo

Vertex have announced positive late-stage clinical trial results for their drug combo to treat cystic fibrosis (CF), taking a leap closer to regulatory filing. Vertex confirmed that the combination of lumacaftor and Kalydeco, resulted in statistically significant improvements in lung function compared to placebo, for patients aged 12 years and over with two copies of

Continue Reading